Comments & Sign-on Letters Archives - Page 8 of 10 - Aimed Alliance

Browsing: Comments & Sign-on Letters

February 13, 2019

Aimed Alliance Submits Public Comment on ICER’s Flawed Drug Pricing Assessment

January 25, 2019

Aimed Alliance Submits Comments on CMS’ Proposal to Weaken Medicare’s Six Protected Classes

December 31, 2018

Aimed Alliance Submits Comments on Advanced Notice of Proposed Rulemaking Regarding “International Pricing Index Model for Medicare Part B Drugs”

December 21, 2018

Aimed Alliance Sends Letter to Ohio Hospitals and Health Systems Warning of Risks of Nonmedical Switching

December 17, 2018

Aimed Alliance Submits Comment Regarding Direct-to-Consumer Pricing Proposed Rule

July 17, 2018

Aimed Alliance Responds to HHS’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

…

November 28, 2016

Aimed Alliance Asks Insurer Not To Engage in Nonmedical Switching Practices

October 20, 2016

Aimed Alliance Asks Institute To Find Value in Psoriasis Medications

September 20, 2016

Aimed Alliance Co-Signs Letter to Senate Judiciary Committee Expressing Concerns that CREATES Act Removes Safety Protections for Patients

Aimed Alliance, one of 16 members of the Patients’ Alliance for Drug Safety Protections (Patients’ Alliance), signed on to a…

September 16, 2016

Aimed Alliance Submits Comment on the Value of Non-Small Cell Lung Cancer Treatments

Previous 1 … 6 7 8 9 10 Next